Tsiporah B. Shore, MD, associate director of the Blood and Bone Marrow Transplant Program discusses stem cell transplantation in patients of multi-ethnic populations who have hematologic malignancies. Read more
Christopher Mason, Ph.D., explains how a new initiative funded by WorldQuant founder Igor Tulchinsky will help medical researchers make better predictions. Read more
Researchers have long struggled to develop preclinical models of colorectal cancer in which the disease forms in the correct anatomical location. Now Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center... Read more
John P. Leonard, M.D., discusses the emergence and potential of chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies. Read more
Using stem cells and three-dimensional organoids, Lukas Dow, Ph.D., and colleagues have created a colon cancer model that more accurately reflects the progression of the disease. Read more
Feature about Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between Christopher Mason and colleagues at Cornell Tech. Read more